Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

How much does kisspeptin-10 cost?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Not covered; there is no approved or lawfully compounded product to cover.

Regulatory: Not eligible for compoundingVerified: Verified Sep 22, 2026
With insurance
Not published
Compounded pharmacy
Not published

What each price includes, with sources

What does kisspeptin-10 cost in each channel?

Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.

Kisspeptin-10 price by purchase channel
ChannelPrice (USD)Notes
With insuranceNot publishedNot covered. Medicare Part D and commercial pharmacy benefits cover FDA approved drugs for accepted indications; compounded or unapproved peptides are paid in cash. [2]
Compounded pharmacyNot publishedNo lawful compounded price. Kisspeptin-10 has been on the 503A Category 2 list since September 29, 2023 and remained there on the FDA page current to April 22, 2026, so 503A pharmacies may not compound it. [1]

Why is there no price for Kisspeptin-10?

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. PeptideAgent has not found an FDA warning letter or review that names Kisspeptin-10. [4] [5] [6]

Clinics and telehealth programs may quote you a cash price for Kisspeptin-10. PeptideAgent lists none, for two reasons. There is no Kisspeptin-10 product to price: none is FDA approved, and a pharmacy has no federal basis to compound it. [1] [7] A quoted price is for a product FDA has not checked for safety, effectiveness, or quality, so it is not the price of a reviewed drug. [8]

If you're going ahead anyway: the checklist on the Kisspeptin-10 page. These steps lower some risks. They do not make the product safe, and they do not give a pharmacy a federal basis to compound Kisspeptin-10, with or without a prescription. [7]

  • Check the pharmacy's license
  • What a legitimate prescription and consult look like
  • Why this is safer than a research-use-only product
  • Questions to ask the pharmacy, the telehealth company, the prescriber, and anyone offering it

What is the list price of kisspeptin-10?

There is no list price and no licensed channel outside clinical trials. Research chemical products sold for human use are unapproved drugs and are not verified for purity.

Does insurance cover kisspeptin-10?

Not covered; there is no approved or lawfully compounded product to cover.

What changes the price?

  • Category 2 listing, which bars compounding

Frequently asked questions

How much does kisspeptin-10 cost without insurance?

No lawful compounded price. Kisspeptin-10 has been on the 503A Category 2 list since September 29, 2023 and remained there on the FDA page current to April 22, 2026, so 503A pharmacies may not compound it. [1]

Does insurance cover kisspeptin-10?

Not covered; there is no approved or lawfully compounded product to cover. [2]

What is the list price of kisspeptin-10?

There is no list price and no licensed channel outside clinical trials. Research chemical products sold for human use are unapproved drugs and are not verified for purity.

Sources

  1. [1]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (Category 2 list and withdrawn nominations, content current as of April 22, 2026)FDA
  2. [2]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)
  3. [3]FDA warning letter 735063, August 24, 2026, to an online seller of research-use-only peptides: products labeled research use only were unapproved new drugs (FDA warning letters database)FDA, 2026
  4. [4]FDA: Compounding inspections, recalls, and other actions (warning letters to compounders)FDA
  5. [5]FDA warning letter 594743, April 1, 2020, to a state-licensed 503A compounding pharmacy (FDA warning letters database)FDA, 2020
  6. [6]FDA to telehealth companies: What to know when promoting compounded drugsFDA, 2026
  7. [7]FDA: Bulk drug substances used in compounding under section 503A of the FD&C ActFDA
  8. [8]FDA: Compounding and the FDA, questions and answersFDA